Experienced in Intestinal Pseudo-Obstruction

Ronit Elhasid

Tel Aviv, TA, IL 
Clinical Trials:Currently Recruiting for 1 Trial
Experienced in Intestinal Pseudo-Obstruction
Tel Aviv, TA, IL 
OverviewLocationsClinical Research

Overview

Ronit Elhasid practices in Tel Aviv, Israel. Mr. Elhasid is rated as an Experienced expert by MediFind in the treatment of Intestinal Pseudo-Obstruction. His top areas of expertise are Mitochondrial Neurogastrointestinal Encephalopathy Disease, Ewing Sarcoma, Turcot Syndrome, Osteosarcoma, and Bone Marrow Transplant.

His clinical research consists of co-authoring 64 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Intestinal Pseudo-Obstruction.

Gender
Male

Locations

Tel Aviv, TA, Israel
Other Locations
Aviv, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Enrollment Status: Recruiting
Publish Date: January 16, 2024
Intervention Type: Drug, Radiation
Study Drugs: VP16, Thiotepa, Treosulfan, Fludarabine, Busulfan, Anti-Thymocyte Globulin, Cyclophosphamide, Grafalon
Study Phase: Phase 2/Phase 3
A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies
A Multicenter, Randomized, Phase III Registration Trial of Transplantation of NiCord®, Ex Vivo Expanded, UCB-derived, Stem and Progenitor Cells, vs. Unmanipulated UCB for Patients With Hematological Malignancies
Enrollment Status: Completed
Publish Date: April 06, 2025
Intervention Type: Drug, Other
Study Drug: Omidubicel
Study Phase: Phase 3
View 1 Less Clinical Trial

64 Total Publications

A Lasting Touch: Fingerprint Memorials Offer Comfort to Grieving Families in Pediatric Palliative Care.
A Lasting Touch: Fingerprint Memorials Offer Comfort to Grieving Families in Pediatric Palliative Care.
Journal: Pediatric blood & cancer
Published: August 29, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Elhasid's expertise for a condition
ConditionClose
    View All 12 Advanced Conditions
    View All 43 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile